Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited’s Net Profit Rose 6.3% in First Half of 2023

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (广州白云山医药集团股份有限公司) (600332.SH) reported a net profit of 2.9 billion yuan in the first half of 2023, up 6.3% year-on-year.

Meanwhile, the company posted 40 billion yuan in revenue, up 7.4% year-on-year.

At the end of the reporting period, it had 73.6 billion yuan in total assets and 38.2 billion yuan in total liabilities, with a liability-to-asset ratio of 51.9%.